Cell Transformation, Neoplastic: Clinical Trials

26 trials for Cell Transformation, Neoplastic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 2 terminated, 2 unknown. 26 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 326Completed 22, Terminated 2, Unknown 2
Phase 22Completed 2

Follow Cell Transformation, Neoplastic: new trials by email Literature Review of Cell Transformation, Neoplastic trials Research Report on Cell Transformation, Neoplastic

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy
Eltrombopag Olamine - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Phase 2 / Phase 3CompletedM.D. Anderson Cancer Center212012-01-132023-09-26
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
ketamine hydrochloride, pharmacogenomic studies, questionnaire administration - Cancer
Phase 3UnknownUniversity of Glasgow2142009-04-012011-05-13
American Ginseng in Treating Patients With Fatigue Caused by Cancer
American ginseng, placebo - Chronic Myeloproliferative Disorders, Fatigue
Phase 3CompletedAlliance for Clinical Trials in Oncology3642008-10-012017-02-09
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
cyclosporine ophthalmic emulsion, placebo - Chronic Myeloproliferative Disorders, Graft Versus Host Disease
Phase 3CompletedVanderbilt-Ingram Cancer Center1642008-10-012017-03-07
Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications
internet-based intervention, questionnaire administration, psychosocial assessment and care - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 3CompletedFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium13372008-08-012012-03-07
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families
educational intervention, informational intervention, internet-based intervention - Chronic Myeloproliferative Disorders, Leukemia
Phase 3CompletedTufts Medical Center1982008-06-012011-07-13
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
educational intervention - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Phase 3CompletedCase Comprehensive Cancer Center5832008-04-012020-07-27
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Fentanyl sublingual spray, Placebo - Cancer
Phase 3CompletedINSYS Therapeutics Inc1302007-10-012014-03-05
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
moxifloxacin hydrochloride, Placebo - Breast Cancer, Chronic Myeloproliferative Disorders
Phase 3TerminatedOHSU Knight Cancer Institute2402006-05-012017-05-09
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
educational intervention, Titrated pain management, questionnaire administration - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Phase 3CompletedVanderbilt-Ingram Cancer Center982005-05-012012-09-06
Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
mycophenolate mofetil, placebo - Cancer
Phase 3TerminatedMartin, Paul1512004-05-012013-05-03
Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
graft versus host disease prophylaxis/therapy, allogeneic bone marrow transplantation, in vitro-treated bone marrow transplantation - Graft Versus Host Disease, Leukemia
Phase 3CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins722002-12-012014-04-17
Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
acyclovir, acyclovir sodium, valacyclovir - Cancer
Phase 3CompletedFred Hutchinson Cancer Center2002-04-012010-09-21
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
cefepime hydrochloride, levofloxacin - Fever, Sweats, and Hot Flashes, Infection
Phase 3UnknownJonsson Comprehensive Cancer Center2001-09-012013-12-19
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
ondansetron, placebo - Chronic Myeloproliferative Disorders, Leukemia
Phase 3CompletedAlliance for Clinical Trials in Oncology1002000-10-012016-07-06
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
caspofungin acetate, liposomal amphotericin B - Cancer
Phase 3CompletedMemorial Sloan Kettering Cancer Center2000-08-012013-01-18
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
Fragmin, placebo - Cervical Cancer, Chronic Myeloproliferative Disorders
Phase 3CompletedJonsson Comprehensive Cancer Center2000-04-012020-08-03
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
St. John's wort - Chronic Myeloproliferative Disorders, Fatigue
Phase 3CompletedMemorial Sloan Kettering Cancer Center1999-12-012013-01-18
Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
captopril, cyclophosphamide, autologous bone marrow transplantation - Cancer
Phase 3CompletedNorthwestern University351999-10-012012-06-06
Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients
liposomal amphotericin B - Cancer
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC1151999-06-012012-09-24

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Blast Crisis (26)  ·  Leukemia, Myeloid, Accelerated Phase (25)  ·  Leukemia, Myeloid, Chronic-Phase (25)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (25)  ·  Burkitt Lymphoma (24)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (23)  ·  Lymphoma, B-Cell, Marginal Zone (23)  ·  Lymphoma, Follicular (23)  ·  Lymphoma, Large B-Cell, Diffuse (23)  ·  Lymphoma, Large-Cell, Immunoblastic (23)  ·  Lymphoma, Mantle-Cell (23)  ·  Lymphoma, Non-Hodgkin (23)  ·  Primary Myelofibrosis (22)  ·  Hodgkin Disease (21)  ·  Leukemia, Myeloid, Acute (21)

Broader conditions

Bone Marrow Diseases (26)  ·  Carcinogenesis (26)  ·  Chronic Disease (26)  ·  Disease Attributes (26)  ·  Hematologic Diseases (26)  ·  Hemic and Lymphatic Diseases (26)  ·  Leukemia, Myeloid (26)  ·  Neoplasms by Histologic Type (26)  ·  Neoplastic Processes (26)  ·  Pathologic Processes (26)  ·  Pathological Conditions, Signs and Symptoms (26)  ·  Immune System Diseases (25)  ·  Immunoproliferative Disorders (25)  ·  Leukemia, Lymphoid (25)

Interventions

Cyclophosphamide (3)  ·  Early Intervention, Educational (3)  ·  Etoposide (2)  ·  Psychiatric Rehabilitation (2)  ·  Radiotherapy (2)  ·  Therapeutics (2)  ·  liposomal amphotericin B (2)  ·  Acyclovir (1)  ·  Antilymphocyte Serum (1)  ·  Asian ginseng (1)  ·  Busulfan (1)  ·  Captopril (1)  ·  Carboplatin (1)  ·  Carmustine (1)  ·  Caspofungin (1)

Sponsors

Fred Hutchinson Cancer Center (3)  ·  Memorial Sloan Kettering Cancer Center (3)  ·  Alliance for Clinical Trials in Oncology (2)  ·  European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Jonsson Comprehensive Cancer Center (2)  ·  Vanderbilt-Ingram Cancer Center (2)  ·  Case Comprehensive Cancer Center (1)  ·  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)  ·  INSYS Therapeutics Inc (1)  ·  M.D. Anderson Cancer Center (1)  ·  Martin, Paul (1)  ·  NCIC Clinical Trials Group (1)  ·  Northwestern University (1)  ·  OHSU Knight Cancer Institute (1)  ·  Roswell Park Cancer Institute (1)

Countries

United States (23)  ·  Canada (3)  ·  Belgium (2)  ·  Czechia (2)  ·  France (2)  ·  Germany (2)  ·  Greece (2)  ·  Israel (2)  ·  Slovakia (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)  ·  Finland (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Barry J.A. Laird, MD (1)  ·  David J. Straus, MD (1)  ·  Debra Barton, RN, PhD, AOCN, FAAN (1)  ·  Eduardo Bruera, MD (1)  ·  Garrett Nichols, MD, MSC (1)  ·  Gautam Borthakur (1)  ·  John A. Glaspy, MD, MPH (1)  ·  Joseph Bubalo, PharmD, BCPS, BCOP (1)  ·  Karen Syrjala (1)  ·  Kent Sepkowitz, MD (1)  ·  Kieren A. Marr, MD (1)  ·  Larry Dillaha, MD (1)  ·  Leo I. Gordon, MD (1)  ·  Madan Jagasia, MD (1)  ·  Marie T. Fallon (1)

Results publications

PMID 15459300, PMID 17397698, PMID 19270260, PMID 22157574, PMID 22480131, PMID 26700120, PMID 26700123, PMID 27020837, PMID 32628342, PMID 33420905, PMID 36282798, PMID 36999619

NIH funding

P30CA068485 (2), P01CA015396 (1), P30CA006973 (1), P30CA008748 (1), P30CA069533 (1), R01CA112631 (1), R01CA119196 (1), R01CA127655 (1)